125 related articles for article (PubMed ID: 23629998)
1. Telangiectatic osteosarcoma.
Colomina J; Peiro A; Trullols L; Garcia I
J Orthop Surg (Hong Kong); 2013 Apr; 21(1):96-9. PubMed ID: 23629998
[TBL] [Abstract][Full Text] [Related]
2. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
Xie L; Guo W; Li Y; Ji T; Sun X
J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
[TBL] [Abstract][Full Text] [Related]
3. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
4. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications.
Scully SP; Ghert MA; Zurakowski D; Thompson RC; Gebhardt MC
J Bone Joint Surg Am; 2002 Jan; 84(1):49-57. PubMed ID: 11792779
[TBL] [Abstract][Full Text] [Related]
5. Pathologic fracture in childhood and adolescent osteosarcoma: A single-institution experience.
Haynes L; Kaste SC; Ness KK; Wu J; Ortega-Laureano L; Bishop M; Neel M; Rao B; Fernandez-Pineda I
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27897381
[TBL] [Abstract][Full Text] [Related]
6. The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture.
Scully SP; Temple HT; O'Keefe RJ; Mankin HJ; Gebhardt M
Clin Orthop Relat Res; 1996 Mar; (324):227-32. PubMed ID: 8595761
[TBL] [Abstract][Full Text] [Related]
7. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.
Zuo D; Zheng L; Sun W; Hua Y; Cai Z
World J Surg Oncol; 2013 Jun; 11():148. PubMed ID: 23799947
[TBL] [Abstract][Full Text] [Related]
8. Telangiectatic osteosarcoma: a review of 87 cases.
Angelini A; Mavrogenis AF; Trovarelli G; Ferrari S; Picci P; Ruggieri P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2197-207. PubMed ID: 27469493
[TBL] [Abstract][Full Text] [Related]
9. The Surgical Treatment and Outcome of Nonmetastatic Extremity Osteosarcoma with Pathological Fractures.
Deng ZP; Ding Y; Puri A; Wang EH; Gulia A; Durban C; Niu XH
Chin Med J (Engl); 2015 Oct; 128(19):2605-8. PubMed ID: 26415798
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of the effect of treatment of osteosarcoma complicated by pathological fracture by neoadjuvant chemotherapy combined with limb salvage surgery.
Zhu J; He T; Wei Z; Wang Y
J BUON; 2018; 23(6):1809-1815. PubMed ID: 30610807
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
12. Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience.
Weiss A; Khoury JD; Hoffer FA; Wu J; Billups CA; Heck RK; Quintana J; Poe D; Rao BN; Daw NC
Cancer; 2007 Apr; 109(8):1627-37. PubMed ID: 17351949
[TBL] [Abstract][Full Text] [Related]
13. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy.
Bacci G; Ferrari S; Longhi A; Donati D; Manfrini M; Giacomini S; Briccoli A; Forni C; Galletti S
Acta Orthop Scand; 2003 Aug; 74(4):449-54. PubMed ID: 14521297
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
15. [Telangiectatic osteosarcoma: report of 10 cases].
Zhang Q; Cai Y; Niu X; Hao L; Ding Y; Yu F
Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):903-5, 50. PubMed ID: 11832192
[TBL] [Abstract][Full Text] [Related]
16. Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival.
Jaffe N; Spears R; Eftekhari F; Robertson R; Cangir A; Takaue Y; Carrasco H; Wallace S; Ayala A; Raymond K
Cancer; 1987 Feb; 59(4):701-9. PubMed ID: 3492261
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of pathologic fracture in osteosarcoma: Evidence based on 1,677 subjects.
Yang M
J Cancer Res Ther; 2015; 11(2):264-7. PubMed ID: 26148581
[TBL] [Abstract][Full Text] [Related]
18. Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma.
Ferguson PC; McLaughlin CE; Griffin AM; Bell RS; Deheshi BM; Wunder JS
J Surg Oncol; 2010 Aug; 102(2):120-4. PubMed ID: 20648581
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
20. Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities? : a systematic review and meta-analysis.
Salunke AA; Chen Y; Tan JH; Chen X; Khin LW; Puhaindran ME
Bone Joint J; 2014 Oct; 96-B(10):1396-403. PubMed ID: 25274928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
